The archive · Health & Care · Product decision · 2013–2026
Oura's ring-to-platform bet reaches its S-1: $1.2B revenue, $16B IPO target
Oura turned a $350 wearable people wear to sleep into a subscription health-data platform — $1.2B nine-month revenue and a public S-1 on 2026-09-03.
Oura
What the business is
Oura, founded in Finland in 2013, makes smart rings priced at $350–$400 that measure sleep, activity, readiness and other biometrics; paired with an app and a paid membership for deeper health metrics, the product is marketed as an always-on health intelligence platform.
How it started
Founded in Finland in 2013, Oura set itself apart from Fitbit, Garmin and Apple Watch with a sleek, unobtrusive ring that tracks activity, sleep and daily readiness. The product started in the niche of biohacking CEOs and performance-minded early adopters before widening into a mainstream sleep-and-recovery brand.
What happened
Revenue scaled from $500M in 2024 to roughly $1B in 2025, with close to $2B expected in 2026. In September 2025 Oura had sold 5.5M rings to date and closed an $875M Series E at about an $11B valuation, with backers including Fidelity, ICONIQ, Whale Rock and Atreides; it confidentially filed for an IPO in May 2026. The company now has more than 900 employees and offices including San Francisco, and faces a proposed class action (filed August 2026 by Clarkson Law Firm) alleging its sleep staging is little more reliable than a coin flip — claims Oura disputes.
How it ended up
On 2026-09-03 Oura publicly filed its S-1 with the SEC. The filing showed revenue of $1.2B for the nine months ended 2026-06-30, up from $697M a year earlier, and reported selling 3.6M rings over the past year with about 5M paid members. Bloomberg reported the company was expected to seek a valuation above $16B, with the offering reportedly planned to raise up to $3B — though no price had been set as of 2026-09-05.
Background
Oura is a Finnish smart-ring company founded in 2013 that sells rings priced at $350–$400, measuring sleep, activity, readiness and other biometrics. Paired with an app, the product is marketed as an always-on health intelligence platform, and a paid membership unlocks deeper health metrics.
The founding bet was on form factor: a sleek, unobtrusive ring that people would wear day and night — including to bed — could capture continuous biometric data that wrist wearables missed, and that data could be sold back as subscription features. From a niche of biohacking CEOs it widened into a mainstream sleep-and-recovery brand as rivals such as Samsung's Galaxy Ring and Whoop crowded in.
The financial arc runs from $500M revenue in 2024 and roughly $1B in 2025 toward close to $2B expected in 2026; an $875M Series E at about an $11B valuation in September 2025; a confidential S-1 in May 2026; and a public S-1 on September 3, 2026 showing $1.2B revenue in the nine months to June 30, 2026, 3.6M rings sold over the past year and about 5M paid members at roughly 85% twelve-month retention.
The filing frames the real asset as the data: nearly 42 billion hours of physiological measurements that power the company's AI models, with expansion aimed at clinical evidence, health plans, employers and care providers. Oura heads toward the IPO under a proposed class action challenging its sleep-staging accuracy, which it disputes.
What has to be true
- The ring is the wedge: unobtrusive enough to sleep in, it captures continuous biometrics that wrist devices miss, making the subscription data valuable.
- Membership economics: roughly 5M paid members with about 85% twelve-month retention turned a one-time hardware sale into recurring revenue that roughly doubled year over year.
- A widening audience: starting with biohacking CEOs, Oura became a mainstream sleep-and-recovery brand as the wearable category filled with rivals.
- The data moat: about 42 billion hours of longitudinal biometrics underpins AI features and the S-1 pitch to health plans, employers and care providers.
- Going public while hot: after the September 2025 Series E at about $11B, a reported valuation above $16B converts growth into a large liquid outcome.
What can be applied
Bet on the form people keep on: Oura's ring captured sleep biometrics wrist wearables missed, and the data platform that followed reached a $1.2B run toward a reported $16B IPO.
Aftermath
As of 2026-09-05 Oura is still private with more than 900 employees, but its S-1 is public and the IPO is the next milestone; Bloomberg-reported figures point to a raise of up to $3B at a valuation above $16B. The registration statement pitches expansion beyond fitness into clinical evidence, health plans, employers and care providers, powered by a dataset Oura puts at nearly 42 billion hours of physiological data across more than 50 health metrics. The proposed sleep-accuracy class action remains pending, and Oura says it will defend against the claims.
Sources
- Oura files to go public
- Oura is reportedly eyeing a September IPO that could value it at more than $16B
- Oura Inc. Form S-1 registration statement (accession 0001193125-26-381855)
- Smart ring maker Oura files to go public
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card